home / stock / achl / achl quote
Last: | $0.9478 |
---|---|
Change Percent: | -1.31% |
Open: | $0.9271 |
Close: | $0.9478 |
High: | $0.959999 |
Low: | $0.9026 |
Volume: | 115,050 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.9478 | $0.9271 | $0.9478 | $0.959999 | $0.9026 | 115,050 | 05-17-2024 |
$0.9151 | $0.9 | $0.9151 | $0.9399 | $0.882201 | 38,551 | 05-16-2024 |
$0.92 | $0.9077 | $0.92 | $0.9298 | $0.8908 | 12,580 | 05-15-2024 |
$0.92 | $0.8986 | $0.92 | $0.929 | $0.8986 | 61,012 | 05-14-2024 |
$0.8898 | $0.938 | $0.8898 | $0.938 | $0.8836 | 71,920 | 05-13-2024 |
$0.9401 | $0.92 | $0.9401 | $0.9703 | $0.9 | 205,541 | 05-10-2024 |
$0.9186 | $0.8713 | $0.9186 | $0.9296 | $0.870001 | 88,041 | 05-09-2024 |
$0.9189 | $0.83 | $0.9189 | $0.93 | $0.821 | 572,117 | 05-08-2024 |
$0.826 | $0.84 | $0.826 | $0.84 | $0.8065 | 67,649 | 05-07-2024 |
$0.8298 | $0.804 | $0.8298 | $0.84 | $0.79 | 195,236 | 05-06-2024 |
$0.8037 | $0.8 | $0.8037 | $0.8478 | $0.79 | 186,701 | 05-03-2024 |
$0.78 | $0.79 | $0.78 | $0.809 | $0.76 | 163,349 | 05-02-2024 |
$0.7818 | $0.7537 | $0.7818 | $0.7897 | $0.7499 | 101,813 | 05-01-2024 |
$0.75 | $0.75 | $0.75 | $0.78 | $0.7455 | 118,993 | 04-30-2024 |
$0.76 | $0.7555 | $0.76 | $0.7794 | $0.748 | 364,419 | 04-29-2024 |
$0.76 | $0.761 | $0.76 | $0.7992 | $0.74 | 382,132 | 04-26-2024 |
$0.7744 | $0.7977 | $0.7744 | $0.8 | $0.74 | 269,377 | 04-25-2024 |
$0.7838 | $0.7742 | $0.7838 | $0.809 | $0.7633 | 110,733 | 04-24-2024 |
$0.7811 | $0.7901 | $0.7811 | $0.8332 | $0.7725 | 111,844 | 04-23-2024 |
$0.79 | $0.791 | $0.79 | $0.8199 | $0.76 | 429,298 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Achilles Therapeutics plc Company Name:
ACHL Stock Symbol:
NASDAQ Market:
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Evaluating the benefit of enhanced host conditioning with further data expected in 2H 2024 – – Strong cash position of $112.3 million support...